# Suzhou Tianma Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-tianma-pharmaceutical

- Industry: Pharmaceuticals
- Headquarters: Suzhou, China
- Website: www.zenjipharma.com
- Latest round: Angel (Sep 21, 2017)
- Investors on record: 2

## About

Founded in 2017 and based in Suzhou, China, Suzhou Tianma Pharmaceutical operates as a pharmaceutical company that focuses on the research and development of raw materials and pharmaceutical intermediates. It was recognized as the National High-tech Enterprise. The company is affiliated to Jiangsu Zhengji Pharmaceutical. In September 2017, Suzhou Tianma Pharmaceutical closed an angel funding. In December 2019, Jiangsu Zenji Pharmaceuticals acquired a majority stake in Suzhou Tianma Pharmaceutical for CNY195 million.

The company is mainly engaged in the research, development, production, and sales of raw materials and pharmaceutical intermediates. It owns products such as citicoline sodium, clopidogrel bisulfate, carbetapentane, and rebamipide.

The company generates revenue by selling raw materials and pharmaceutical intermediates.

## Funding rounds

- Angel, Sep 21, 2017 — China Soft Capital, Langcheng Capital

## Investors

- China Soft Capital (https://capitalatlas.ai/funds/china-soft-capital) — Angel
- Langcheng Capital (https://capitalatlas.ai/funds/langcheng-capital) — Angel